A randomized dose-response trial of a single injection of corifollitropin alfa to sustain multifollicular growth during controlled ovarian stimulation. - Wikidata - awgldk - TriplyDB

A randomized dose-response trial of a single injection of corifollitropin alfa to sustain multifollicular growth during controlled ovarian stimulation.

A randomized dose-response trial of a single injection of corifollitropin alfa to sustain multifollicular growth during controlled ovarian stimulation.

http://www.wikidata.org/entity/Q48742001

about

Long-acting FSH versus daily FSH for women undergoing assisted reproduction Luteal phase support for assisted reproduction cycles Luteal phase support for assisted reproduction cycles Clinical impact of LH rises prior to and during ganirelix treatment started on day 5 or on day 6 of ovarian stimulation.Gonadotrophins: The future.A double-blind, non-inferiority RCT comparing corifollitropin alfa and recombinant FSH during the first seven days of ovarian stimulation using a GnRH antagonist protocol.The role of corifollitropin alfa in controlled ovarian stimulation for IVF in combination with GnRH antagonist.Corifollitropin alfa compared to daily FSH in controlled ovarian stimulation for in vitro fertilization: a meta-analysis Efficacy of corifollitropin alfa followed by recombinant follicle-stimulating hormone in a gonadotropin-releasing hormone antagonist protocol for Korean women undergoing assisted reproduction.Impact of patient characteristics on the pharmacokinetics of corifollitropin alfa during controlled ovarian stimulation Effectiveness of corifollitropin alfa used for ovarian stimulation of poor responder patients Advances in recombinant DNA technology: corifollitropin alfa, a hybrid molecule with sustained follicle-stimulating activity and reduced injection frequency.The mammalian ovary from genesis to revelation.Corifollitropin alfa: a novel long-acting recombinant follicle-stimulating hormone agonist for controlled ovarian stimulation.Corifollitropin alfa: a review of its use in controlled ovarian stimulation for assisted reproduction.Corifollitropin alfa compared with follitropin beta in poor responders undergoing ICSI: a randomized controlled trial.Development and characterization of a novel long-acting recombinant follicle stimulating hormone agonist by fusing Fc to an FSH-β subunit.Administration of corifollitropin alfa on Day 2 versus Day 4 of the cycle in a GnRH antagonist protocol: a randomized controlled pilot study.Gonadotropin stimulation: past, present and future.Corifollitropin alfa compared with follitropin beta in GnRH-antagonist ovarian stimulation protocols in an unselected population undergoing IVF/ICSI

P2860

Q24186504-C57820EF-3C99-49C2-BA8D-996F3A81128E Q24186532-BB514754-32DF-4B8A-B092-2F81FD729E04 Q24235807-4A562822-143B-45C4-A680-4E1CE1B6B412 Q34656033-E75D5040-324D-41FA-AA7B-20196F795621 Q34975528-475E6384-EFA0-454A-A8EF-8A23C38EFC96 Q34997672-6EA0B1FC-2A3A-4A97-A785-004B0C184E7D Q35186161-B0A27747-DA9E-4412-B861-38127D6EAF21 Q35735337-3A9E2D95-EC22-45A1-A207-DC63368B2DC4 Q35833291-D142F44F-3AEF-444C-B433-A85A379C7200 Q37030672-848C1F36-29E6-4C76-B761-BAC3B6B60608 Q37358128-17BDE464-9D68-468A-A6AF-6AA726CD482B Q37381361-97B6A920-2132-4AD1-B6D4-CE168EC53E79 Q37385514-629DF6BF-B15D-4261-BE84-502F3BE04417 Q37795798-D3E910FB-E7BF-4E27-8BD4-3A69BC623F00 Q37911498-0F635CEE-36C9-4870-9F3F-E91309D5B1DE Q41708984-EEBDAF4C-056B-46F6-8BE4-C6DCAD2D55E0 Q48563210-0DFABF5F-C499-43E3-A13E-4A087BF720BB Q48602680-F4D196DA-FDD0-459D-A732-828B95E81135 Q55255771-781C4A51-BDF8-4AC1-8C71-08B51C6D3B28 Q58369569-85CA8163-2F82-493E-96AF-9DF58FB2DA95

P2860

A randomized dose-response trial of a single injection of corifollitropin alfa to sustain multifollicular growth during controlled ovarian stimulation.

http://www.wikidata.org/entity/Q48742001

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh

2008年學術文章

@zh-hant

name

A randomized dose-response tri ...... ontrolled ovarian stimulation.

@en

A randomized dose-response tri ...... ontrolled ovarian stimulation.

@nl

type

label

A randomized dose-response tri ...... ontrolled ovarian stimulation.

@en

A randomized dose-response tri ...... ontrolled ovarian stimulation.

@nl

prefLabel

A randomized dose-response tri ...... ontrolled ovarian stimulation.

@en

A randomized dose-response tri ...... ontrolled ovarian stimulation.

@nl

P1433

Q48742001-7CAAC4B7-95AA-499D-B7F1-D1D28347B2B6

P1476

Q48742001-E7397ADE-555A-4DDE-86C3-F8FC7A6AC0B9

P2093

Q48742001-6DE4183D-5A8F-436E-B9B3-E672ACB2816B

P2860

Q48742001-0E561980-C326-4BFC-B799-54DD28133C18

Q48742001-1D0C221A-A99F-4D75-ABD1-B104BC2F4487

Q48742001-3A37DEBD-714E-40B0-B6B8-0B6732D5A557

Q48742001-3B1BEB5C-96FC-4E18-9B97-0B4C0AF02357

Q48742001-6349ECB7-2EBD-4C33-A1D2-D3DF7B5CCFE7

Q48742001-69E8CB23-7891-4764-9E6F-8494C2867DF6

Q48742001-7290983C-6090-404B-98BA-3D2CA990241F

Q48742001-76C25415-7441-4602-8201-E80037FB39AB

Q48742001-8A01AFD4-FDC4-4AD6-B334-B68DB876FA11

Q48742001-95B8AC77-5152-4DD7-B4AC-DA4FD6D023C4

P304

Q48742001-CF5C5485-B83A-4F2B-AAFA-06C9BA9D926D

P31

Q48742001-E4616888-ADCE-43B5-BDF4-0C8263527DBC

P356

Q48742001-2506188A-2639-48D9-859D-B055C44CFEE0

P407

Q48742001-3067A9E7-FD6E-4264-93AC-DAFD9DF9E9A3

P433

Q48742001-E4062E26-2E61-4655-9040-BAF9B50673DB

P478

Q48742001-71255CDC-3D0D-4EF9-A502-F02791D044A2

P577

Q48742001-11BE0DDC-0CA7-4462-A7C4-3FF6D61C129F

P5875

Q48742001-6FD29603-3631-4528-B9A5-C00B72174613

P698

Q48742001-EA7C9E87-FF23-4E53-8BCF-00EB3F79D94C

P356

P1433

Human Reproduction

P1476

A randomized dose-response tri ...... ontrolled ovarian stimulation.

@en

P2093

Corifollitropin Alfa Dose-finding Study Group

http://www.w3.org/2001/XMLSchema#string

P2860

GnRH antagonists in ovarian stimulation for IVF.

Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis.

Design of a long-acting follitropin agonist by fusing the C-terminal sequence of the chorionic gonadotropin beta subunit to the follitropin beta subunit.

Clinical profiling of recombinant follicle stimulating hormone (rFSH; Puregon): relationship between serum FSH and efficacy.

Glycosylation of an N-terminal extension prolongs the half-life and increases the in vivo activity of follicle stimulating hormone.

Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation.

First human exposure to FSH-CTP in hypogonadotrophic hypogonadal males.

Single dose pharmacokinetics and effects on follicular growth and serum hormones of a long-acting recombinant FSH preparation (FSH-CTP) in healthy pituitary-suppressed females.

A randomized, double-blind, multicentre clinical trial comparing starting doses of 150 and 200 IU of recombinant FSH in women treated with the GnRH antagonist ganirelix for assisted reproduction.

Pharmacodynamics of a single low dose of long-acting recombinant follicle-stimulating hormone (FSH-carboxy terminal peptide, corifollitropin alfa) in women with World Health Organization group II anovulatory infertility.

P304

2484-2492

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/HUMREP/DEN288

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P577

2008-08-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

31365524

http://www.w3.org/2001/XMLSchema#string

P698

18684735

http://www.w3.org/2001/XMLSchema#string